Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and treatment. Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection.

Related collections

Author and article information

Journal

Title: JAMA

Abbreviated Title: JAMA

Publisher: American Medical Association (AMA)

ISSN (Print): 0098-7484

Publication date (Electronic): April 13 2020

Affiliations

[1 ]Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas

[2 ]Division of Infectious Diseases and Geographic Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas

[3 ]Pharmacy Service, VA North Texas Health Care System, Dallas

Article

DOI: 10.1001/jama.2020.6019

PubMed ID: 32282022

SO-VID: f5ed2db4-8835-44d6-b2f1-d8084edec73c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1,161

See all cited by

- Version 1

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) : A Review

Read this article at